John Deere Plans Major U.S. Manufacturing Changes


Deere will shift production of windrowers, round balers, Hagie sprayers and small planters as part of a multi-year manufacturing restructuring.

John Deere is making significant changes to its U.S. manufacturing network, including plans to close two Iowa factories, shift production among several American plants, and consolidate sugar cane harvester manufacturing in Brazil.

The company says the changes are intended to better align manufacturing capacity with customer demand while concentrating investment in modern, heavily utilized U.S. facilities.

For farmers, the moves will change where several familiar pieces of John Deere agricultural equipment are manufactured over the next several years, including windrowers, round balers, Hagie STS sprayers and small planters.

Ottumwa Works to close

One of the biggest changes involves John Deere’s Ottumwa Works in Iowa.

Deere plans to transfer windrower production from Ottumwa to Des Moines Works by the end of fiscal year 2027. Round baler production is expected to follow by the end of fiscal year 2028.

After those transfers are completed, Deere intends to close the Ottumwa factory.

The company attributed the decision to changes in customer demand and the manufacturing capacity available elsewhere within its network.

The move does not mean Deere is ending production of the equipment. Instead, manufacturing will be consolidated at another U.S. Deere facility.

Hagie sprayer production moving to Louisiana

Another Iowa operation will eventually cease manufacturing.

Starting in fiscal year 2028, Deere plans to move production of Hagie STS sprayers from Clarion, Iowa, to its factory in Thibodaux, Louisiana.

Manufacturing operations at the Hagie factory in Clarion are then expected to end by fiscal year 2029.

The Thibodaux facility will therefore gain sprayer production as Deere reorganizes manufacturing capacity across its U.S. operations.

Sugar cane harvester production moving to Brazil

Thibodaux will also see another significant change.

In fiscal year 2029, Deere intends to move sugar cane harvester production from Louisiana to Catalão, Brazil, where the company already manufactures sugar cane harvesters.

Deere said consolidating production in Brazil will place manufacturing closer to the largest concentration of customer demand in South America while allowing the company to produce the machines at a single location.

The Louisiana factory currently produces approximately 35 sugar cane harvesters annually for the U.S. market.

While this represents a transfer of some manufacturing outside the United States, Deere’s broader announcement emphasizes its continued investment in American manufacturing and its strategy of concentrating U.S. production in facilities where the company sees the greatest long-term value.

Small planter production moving to Iowa

John Deere is also changing where some of its planting equipment is manufactured.

In fiscal year 2027, small planter production is scheduled to move from John Deere Seeding in Moline, Illinois, to the company’s facility in Paton, Iowa.

As with the windrower, baler and sprayer changes, production will remain within Deere’s U.S. manufacturing network.

Construction and forestry operations under review

Deere is also evaluating strategic sourcing opportunities within its Construction and Forestry Division.

According to the company, that review is designed to improve competitiveness and flexibility, manage costs, and allow greater investment in areas including product development, technology, field sales and customer support.

Deere characterized the review as part of a broader industry response to changing market conditions, shifts in customer demand and global cost pressures.

The company did not announce specific plant closures or production transfers related to the Construction and Forestry review in the release.

What the changes mean for Deere customers

Despite the multi-year manufacturing transition, Deere says it expects to continue serving customers without disruption.

The company plans to manage the transfers with the goal of maintaining equipment quality, product availability and service.

For farmers, that means the immediate significance of the announcement is primarily where equipment will be manufactured rather than whether the affected product lines will remain available.

The changes will unfold over several years, with the first production transfers planned for fiscal year 2027 and other moves continuing through fiscal year 2029.

Deere says concentrating investments in modern, high-use facilities will help preserve and expand critical U.S. manufacturing capabilities while supporting the company’s competitiveness and its ability to continue investing during changing business cycles.

Iowa communities face plant closures

The biggest local impacts could be felt in Ottumwa and Clarion, Iowa, where Deere intends to eventually end manufacturing operations.

The company acknowledged that the decisions will affect employees and communities.

During the transition, Deere says it will engage with employees, union representatives where applicable, local leaders and community stakeholders.

The company has also committed to identifying what it describes as the best future use for the Ottumwa and Clarion properties.

Free Training

Source link

Lonza to Acquire Five Merck CDMO Sites, Doubles US Manufacturing Footprint


Lonza will acquire five Merck CDMO facilities across the US, strengthening its bioconjugate, viral vector and advanced drug manufacturing capabilities.


Lonza has signed a definitive agreement to acquire five contract development and manufacturing organization (CDMO) facilities in the United States from Merck KGaA, Darmstadt, Germany, in a deal valued in the low- to mid-triple-digit millions of Swiss francs. The transaction will significantly expand Lonza’s US manufacturing presence and strengthen its position in the rapidly growing biopharmaceutical manufacturing market.


The acquisition will increase Lonza’s US CDMO manufacturing network from four facilities to nine, adding approximately 1,100 highly skilled employees to its global workforce. Following the transaction, Lonza’s US employee base is expected to exceed 6,000. The acquired facilities will provide capabilities spanning clinical development through commercial-scale manufacturing, supporting pharmaceutical customers across several high-growth technology segments.


The five facilities bring complementary manufacturing and development capabilities. The St. Louis, Missouri, site specializes in bioconjugates, while the Madison and Verona facilities in Wisconsin manufacture high-potency payload-linkers. The Carlsbad, California, facility provides end-to-end viral vector solutions, including aseptic fill-finish capabilities. Meanwhile, the Indianapolis, Indiana, site supports lipid nanoparticles, liposomes and PEGylated protein solutions, also incorporating aseptic fill-finish operations.


These capabilities position Lonza to strengthen its exposure to antibody-drug conjugates (ADCs), other bioconjugates, viral vectors for cell and gene therapies, and advanced drug-delivery technologies. The acquisition also complements the company’s ongoing CDMO readiness investment in Vacaville, California, and its recently announced commercial spray-drying facility investment in Bend, Oregon.


Lonza CEO Wolfgang Wienand said the acquisition aligns with the company’s One Lonza Strategy and its disciplined capital allocation approach. He highlighted increasing demand for bioconjugates and viral vectors, noting that the additional facilities will strengthen the company’s ability to support customers from early-stage innovation through commercial product launches.


For Merck KGaA, the divestment represents another step in its strategy to concentrate its Life Science portfolio and direct investments towards strengthening scientific leadership and customer partnerships. Group CEO Kai Beckmann expressed confidence that Lonza would build on the operational foundation established by Merck’s CDMO teams.


The acquired operations are expected to generate approximately CHF 250 million in sales in full-year 2028, with a CORE EBITDA margin below Lonza’s existing group margin. Although the initial contribution to group performance is expected to be insignificant, Lonza anticipates considerable profitable growth following integration. The company expects the acquired business to reach peak sales at its future group margin level by the mid-2030s.


The transaction will be financed through available cash and existing credit facilities, with Lonza maintaining its BBB+ credit rating. Completion is expected by mid-2027, subject to customary closing conditions. Until closing, both companies will continue operating the businesses independently.


Following completion, Lonza will prioritize customer continuity, employee support and integration of the five facilities into its global manufacturing network. The acquisition will not affect its previously announced share buyback following the divestment of its Capsules & Health Ingredients business.


Product Impact and Chemical Commodity Price Impact


The acquisition will strengthen the availability of specialized CDMO services for antibody-drug conjugates, viral vectors, lipid nanoparticles and advanced biopharmaceutical formulations. Increased manufacturing capacity could improve pharmaceutical supply-chain resilience, reduce production bottlenecks and support the commercialization of complex therapies. Demand for high-purity solvents, specialty chemicals, pharmaceutical-grade excipients, lipids, PEG-based materials and bioconjugation reagents may increase as the acquired facilities expand operations. However, the transaction is unlikely to create an immediate price movement across bulk chemical commodities such as methanol, benzene, ethylene or propylene. Any upward pressure on specialty input prices will depend on actual production expansion, procurement volumes and supplier availability.

Free Training

Source link

U.S. Manufacturing PMI Hits 55.5% in October, Tenth Month of Growth – News and Statistics


Nov 3, 2026

U.S. manufacturing activity expanded for a tenth consecutive month in October, supported by faster production and steady growth in new factory orders, according to the Institute for Supply Management. The institute reported that its Manufacturing Purchasing Managers Index came in at 55.5 percent for the month, a gain of 1.0 percentage point from September.

The reading follows a ten-month contraction and, in the institute’s assessment, points to growth across the broader U.S. economy for a 24th straight month. Its economic modeling associates an October PMI of 55.5 percent with a 2.7 percent annualized rise in real gross domestic product.

Real GDP growth, year on year (quarterly), United States2.10% · Q3 2026 · ▼ 0.1 pp

201520202025

Source: U.S. Bureau of Economic Analysis

Susan Spence, chair of the institute’s Manufacturing Business Survey Committee, said manufacturing stayed in expansion territory during the month. She noted that four of the five subindexes making up the PMI grew faster than in September, while employment growth slowed by 0.3 percentage point.

The Production Index rose 2.3 percentage points to 59.0 percent from 56.7 percent in September, the highest level since November 2021 and a 12th consecutive month of expansion. The New Orders Index reached 55.5 percent, up 0.2 percentage point from September, for a tenth month of growth. The Backlog of Orders Index slipped 1.8 percentage points to 54.6 percent but remained in expansion for a tenth month.

Survey respondents in high-tech and defense markets described strong demand alongside severe lead-time pressure. One machinery-sector executive reported rapid growth in semiconductor and government and defense work, with lead times and prices climbing and some delays reminiscent of the Covid-19 period. A manager in miscellaneous manufacturing said commodities used by data centers remain constrained in both supply and pricing.

Demand for capital goods outside those areas showed hesitation. A computer and electronic products executive cited uncertainty in the Middle East, Eastern Europe and China, along with questions over research funding, as factors shaping customer purchasing behavior.

Employment expanded for a fourth consecutive month, though at a slightly slower pace. The Employment Index registered 52.4 percent, down 0.3 percentage point from September, and respondents favored hiring over reducing headcount by a ratio of 1.8 to 1. Eight industries reported employment growth, including four of the six largest sectors.

Raw materials inventories returned to expansion after contracting in September. The Inventories Index rose 2.8 percentage points to 51.4 percent, with seven industries expanding inventories.

Cost pressures remained a concern even as price inflation decelerated. The Prices Index registered 75.2 percent, down 2.7 percentage points from September, while still indicating a 25th consecutive month of higher raw material prices. Spence attributed the reading to higher steel and aluminum prices, tariffs on many imported goods, and rising petroleum-based products tied to the Middle East conflict.

Aluminum3,283 USD/mt · Sep 2026 · ▲ 1.0%

20222023202420252026

Source: World Bank Commodity Price Data (Pink Sheet) · CC BY 4.0

Supply chain bottlenecks worsened slightly. The Supplier Deliveries Index edged up 0.1 percentage point to 59.1 percent, marking an 11th consecutive month of slower delivery performance, with five of the six largest manufacturing industries reporting delays.

Respondents said tariffs and trade policies continued to complicate planning. A primary metals respondent cited material shortages, high fuel costs and persistent uncertainty, and said Canadian tariffs continue to hurt steel. A fabricated metal products executive said policies from Washington weigh on business conditions and that Canadian tariffs damage small U.S. businesses selling into that market.

The institute also reported that 6 percent of manufacturing GDP contracted in October, up from 2 percent in September, and that the share of sector GDP in strong contraction rose to 6 percent from 2 percent. Spence described the share of sector GDP at or below 45 percent as a useful gauge of overall manufacturing weakness.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND THE AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional EditionPRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and its Prospects

    1. MARKET SIZE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    2. CONSUMPTION BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    3. MARKET FORECAST TO 2035
  4. 4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION

    Finding New Products to Diversify Your Business

    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCTS
    4. MOST TRADED PRODUCTS
    5. MOST PROFITABLE PRODUCTS FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Export

    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    2. PRODUCTION BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    2. IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    3. IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    2. EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    3. EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition
    PRO

    1. 11.1

      United States

      • Market Size
      • Production
      • Imports
      • Exports
    2. 11.2

      China

      • Market Size
      • Production
      • Imports
      • Exports
    3. 11.3

      Japan

      • Market Size
      • Production
      • Imports
      • Exports
    4. 11.4

      Germany

      • Market Size
      • Production
      • Imports
      • Exports
    5. 11.5

      United Kingdom

      • Market Size
      • Production
      • Imports
      • Exports
    6. 11.6

      France

      • Market Size
      • Production
      • Imports
      • Exports
    7. 11.7

      Brazil

      • Market Size
      • Production
      • Imports
      • Exports
    8. 11.8

      Italy

      • Market Size
      • Production
      • Imports
      • Exports
    9. 11.9

      Russian Federation

      • Market Size
      • Production
      • Imports
      • Exports
    10. 11.10

      India

      • Market Size
      • Production
      • Imports
      • Exports
    11. 11.11

      Canada

      • Market Size
      • Production
      • Imports
      • Exports
    12. 11.12

      Australia

      • Market Size
      • Production
      • Imports
      • Exports
    13. 11.13

      Republic of Korea

      • Market Size
      • Production
      • Imports
      • Exports
    14. 11.14

      Spain

      • Market Size
      • Production
      • Imports
      • Exports
    15. 11.15

      Mexico

      • Market Size
      • Production
      • Imports
      • Exports
    16. 11.16

      Indonesia

      • Market Size
      • Production
      • Imports
      • Exports
    17. 11.17

      Netherlands

      • Market Size
      • Production
      • Imports
      • Exports
    18. 11.18

      Turkey

      • Market Size
      • Production
      • Imports
      • Exports
    19. 11.19

      Saudi Arabia

      • Market Size
      • Production
      • Imports
      • Exports
    20. 11.20

      Switzerland

      • Market Size
      • Production
      • Imports
      • Exports
    21. 11.21

      Sweden

      • Market Size
      • Production
      • Imports
      • Exports
    22. 11.22

      Nigeria

      • Market Size
      • Production
      • Imports
      • Exports
    23. 11.23

      Poland

      • Market Size
      • Production
      • Imports
      • Exports
    24. 11.24

      Belgium

      • Market Size
      • Production
      • Imports
      • Exports
    25. 11.25

      Argentina

      • Market Size
      • Production
      • Imports
      • Exports
    26. 11.26

      Norway

      • Market Size
      • Production
      • Imports
      • Exports
    27. 11.27

      Austria

      • Market Size
      • Production
      • Imports
      • Exports
    28. 11.28

      Thailand

      • Market Size
      • Production
      • Imports
      • Exports
    29. 11.29

      United Arab Emirates

      • Market Size
      • Production
      • Imports
      • Exports
    30. 11.30

      Colombia

      • Market Size
      • Production
      • Imports
      • Exports
    31. 11.31

      Denmark

      • Market Size
      • Production
      • Imports
      • Exports
    32. 11.32

      South Africa

      • Market Size
      • Production
      • Imports
      • Exports
    33. 11.33

      Malaysia

      • Market Size
      • Production
      • Imports
      • Exports
    34. 11.34

      Israel

      • Market Size
      • Production
      • Imports
      • Exports
    35. 11.35

      Singapore

      • Market Size
      • Production
      • Imports
      • Exports
    36. 11.36

      Egypt

      • Market Size
      • Production
      • Imports
      • Exports
    37. 11.37

      Philippines

      • Market Size
      • Production
      • Imports
      • Exports
    38. 11.38

      Finland

      • Market Size
      • Production
      • Imports
      • Exports
    39. 11.39

      Chile

      • Market Size
      • Production
      • Imports
      • Exports
    40. 11.40

      Ireland

      • Market Size
      • Production
      • Imports
      • Exports
    41. 11.41

      Pakistan

      • Market Size
      • Production
      • Imports
      • Exports
    42. 11.42

      Greece

      • Market Size
      • Production
      • Imports
      • Exports
    43. 11.43

      Portugal

      • Market Size
      • Production
      • Imports
      • Exports
    44. 11.44

      Kazakhstan

      • Market Size
      • Production
      • Imports
      • Exports
    45. 11.45

      Algeria

      • Market Size
      • Production
      • Imports
      • Exports
    46. 11.46

      Czech Republic

      • Market Size
      • Production
      • Imports
      • Exports
    47. 11.47

      Qatar

      • Market Size
      • Production
      • Imports
      • Exports
    48. 11.48

      Peru

      • Market Size
      • Production
      • Imports
      • Exports
    49. 11.49

      Romania

      • Market Size
      • Production
      • Imports
      • Exports
    50. 11.50

      Vietnam

      • Market Size
      • Production
      • Imports
      • Exports
  12. LIST OF TABLES

    1. Key Findings In 2025
    2. Market Volume, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    3. Market Value: Historical Data (2012–2025) and Forecast (2026–2035)
    4. Per Capita Consumption, by Country, 2022–2025
    5. Production, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
    6. Imports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
    7. Imports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
    8. Import Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
    9. Exports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
    10. Exports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
    11. Export Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    2. Market Value: Historical Data (2012–2025) and Forecast (2026–2035)
    3. Consumption, by Country, 2025
    4. Market Volume Forecast to 2035
    5. Market Value Forecast to 2035
    6. Market Size and Growth, By Product
    7. Average Per Capita Consumption, By Product
    8. Exports and Growth, By Product
    9. Export Prices and Growth, By Product
    10. Production Volume and Growth
    11. Exports and Growth
    12. Export Prices and Growth
    13. Market Size and Growth
    14. Per Capita Consumption
    15. Imports and Growth
    16. Import Prices
    17. Production, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    18. Production, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    19. Production, by Country, 2025
    20. Production, In Physical Terms, by Country: Historical Data (2012–2025) and Forecast (2026–2035)
    21. Imports, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    22. Imports, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    23. Imports, In Physical Terms, By Country, 2025
    24. Imports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
    25. Imports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
    26. Import Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
    27. Exports, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    28. Exports, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    29. Exports, In Physical Terms, By Country, 2025
    30. Exports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
    31. Exports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
    32. Export Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)

Free Training

Source link